On July 12, the Food and Drug Administration (FDA) approved Xiidra (lifitegrast ophthalmic solution) for the treatment of signs and symptoms of dry eye disease. Read more …
Reader Survey
Please share your feedback! We’re interested to learn more about your experience with American Nurse Journal.